ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis
Abstract Background ANXA2 (Annexin A2) is a pleiotropic calcium-dependent phospholipid binding protein that is abnormally expressed in various cancers. We previously found that ANXA2 is upregulated in esophageal squamous cell carcinoma (ESCC). This study was designed to investigate the functional si...
Main Authors: | Sai Ma, Chen-Chen Lu, Li-Yan Yang, Juan-Juan Wang, Bo-Shi Wang, Hong-Qing Cai, Jia-Jie Hao, Xin Xu, Yan Cai, Yu Zhang, Ming-Rong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-018-0851-y |
Similar Items
-
The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy
by: Yen-Hao Chen, et al.
Published: (2018-08-01) -
Overexpression of VEGF-C and MMP-9 predicts poor prognosis in Kazakh patients with esophageal squamous cell carcinoma
by: Jiangfen Li, et al.
Published: (2019-12-01) -
c-myc Amplification Is Frequent in Esophageal Adenocarcinoma and Correlated with the Upregulation of VEGF-A Expression
by: Burkhard H.A. von Rahden, et al.
Published: (2006-09-01) -
Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinoma
by: Li J, et al.
Published: (2017-08-01) -
Metastatic squamous cell carcinoma of colon from esophageal cancer
by: Natasha Garg, et al.
Published: (2017-04-01)